Triciribine

DB12405InvestigationalSmall molecule

Triciribine has been used in trials studying the treatment of Leukemia, Ovarian Cancer, HER2/Neu Negative, Breast Adenocarcinoma, and Stage IV Breast Cancer, among others.

Formula / weight: C₁₃H₁₆N₆O₄ · 320.309 g/mol (avg)
Also known as: Pentaazacentopthylene · TCN
Code names: NSC-154020

Resolves to

Compound

UNII2421HMY9N6CAS35943-35-2ChEMBLCHEMBL331237ChEBI65310PubChem65399

Structure

InChIKeyHOGVTUZUJGHKPL-HTVVRFAVSA-NSMILESCN1N=C(N)C2=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C3=C2C1=NC=N3

Targets

P03366gag-pol

What you can answer from here — as of September 12, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Triciribine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account